Safety and immunologic efficacy of personalized multiple HLA class I-restricted peptide vaccines for breast cancer patients in the adjuvant setting.
Uhi Toh
No relevant relationships to disclose
Nobutaka Iwakuma
No relevant relationships to disclose
Mai Mishima
No relevant relationships to disclose
Miki Takenaka
No relevant relationships to disclose
Ryuji Takahashi
No relevant relationships to disclose
Mina Furukawa
No relevant relationships to disclose
Teruhiko Fujii
No relevant relationships to disclose
Etsuyo Ogo
No relevant relationships to disclose
Shino Nakagawa
No relevant relationships to disclose
Maki Tanaka
No relevant relationships to disclose
Tetsuro Sasada
No relevant relationships to disclose
Kyogo Itoh
No relevant relationships to disclose
Yoshito Akagi
No relevant relationships to disclose